Corvel Corp.
CRVL
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.18B
Close$
$52.36
15.7% downside
Current Fair Value
15.7% downsideOvervalued by 15.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.18 Billion |
|---|---|
| Enterprise Value | $2.96 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.15 |
| Beta | 0.98 |
| Outstanding Shares | 51,150,000 |
Return
| Return on Equity | 21.19% |
|---|---|
| Return on Assets | 12.99% |
| Return on Invested Capital | 25.51% |
Valuation & Multiples
| P/E Ratio | 28.97 |
|---|---|
| PEG | 166.03 |
| Price to Sales | 3.45 |
| Price to Book Ratio | 8.87 |
| Enterprise Value to Revenue | 3.09 |
| Enterprise Value to EBIT | 28.02 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.25%▼ 52.38% |
|---|---|
| Total Invested | $7.90M▼ 99.47% |
| Investors Holding | 12▼ 270.00% |
ESG Score
No data
About Corvel Corp.
Relevant Senate Committees
Finance
Controls Medicare and Medicaid policy; decisions on whether to expand dental benefits under these programs represent the largest potential volume catalyst for labs.
Health, Education, Labor, and Pensions
Regulates the FDA, which provides oversight for dental devices and materials; also influences labor costs and workplace safety in labs.
Special Committee on Aging
Focuses on issues affecting seniors, including dental health and the affordability of dentures/prosthetics, often driving legislative interest in Medicare dental coverage.